Full Event Guide
The Only Event Uniting Key B & T Cell, Autoimmunity & Inflammation Decision-Makers to Advance the Therapeutic Future of Autoimmune Diseases
Having trouble downloading the brochure? Let us know and we’ll email it to you instead.
Key Takeaways You Cannot Afford to Miss
- Compare the landscape of B & T cell-mediated autoimmune diseases with Gossamer Bio, NYSCF, and Immunic
- Explore the latest developments of the leading drug targets and therapeutics with COUR Pharmaceuticals, Novo Nordisk, and Cabaletta Bio
- Overcome the challenges in mapping the therapeutic target landscape for B-cell mediated autoimmune disease & T-cell dependent autoantibody responses with Duke University
2021 Attending Companies Included:
